Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation

Cancer Letters

Volumn 290, Issue 2, 2010, Pages 238-247

  Zhao, Jinbo ^a   Zhou, Yongan ^a   Zhang, Zhipei ^a   Tian, Feng ^a   Ma, Nan ^a   Liu, Tonggang ^a   Gu, Zhongping ^a   Wang, Yunjie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fascin1; Invasiveness; Migration; Non small cell lung cancer; Proliferation

Indexed keywords

ACTIN BINDING PROTEIN; FASCIN1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL ASSAY; CELL CLONE; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77649193089     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.09.013     Document Type: Article

References (59)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. Scagliotti G. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages. Lung Cancer 38 suppl. 3 (2002) S23-S29
3. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
4. Friedl P., and Wolf K. Tumour-cell invasion, migration: diversity and escape mechanisms. Nat. Rev. Cancer 3 (2003) 362-374
5. Pollard T.D., and Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112 (2003) 453-465
6. Adams J.C. Fascin protrusions in cell interactions. Trends Cardiovas. Med. 14 (2004) 221-226
7. Adams J.C. Roles of fascin in cell adhesion and motility. Curr. Opin. Cell Biol. 16 (2004) 590-596
8. Kane R.E. Preparation and purification of polymerized actin from sea urchin egg extracts. J. Cell Biol. 66 (1975) 305-315
9. Hashimoto Y., Skacel M., and Adams J.C. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int. J. Biochem. Cell Biol. 37 (2005) 1787-1804
10. Hashimoto Y., Ito T., Inoue H., Okumura T., Tanaka E., Tsunoda S., Higashiyama M., Watanabe G., Imamura M., and Shimada Y. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 11 (2005) 2597-2605
11. Zhang H., Xu L., Xiao D., Xie J., Zeng H., Cai W., Niu Y., Yang Z., Shen Z., and Li E. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J. Clin. Pathol. 59 (2006) 958-964
12. Hsu K.F., Lin C.K., Yu C.P., Tzao C., Lee S.C., Lee Y.Y., Tsai W.C., and Jin J.S. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis. Esophagus. 22 (2009) 402-408
13. Hashimoto Y., Shimada Y., Kawamura J., Yamasaki S., and Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67 (2004) 262-270
14. Tsai W.C., Jin J.S., Chang W.K., Chan D.C., Yeh M.K., Cherng S.C., Lin L.F., Sheu L.F., and Chao Y.C. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters. J. Histochem. Cytochem. 55 (2007) 955-962
15. Li X., Zheng H., Hara T., Takahashi H., Masuda S., Wang Z., Yang X., Guan Y., and Takano Y. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int. J. Oncol. 33 (2008) 69-79
16. Jawhari A.U., Buda A., Jenkins M., Shehzad K., Sarraf C., Noda M., Farthing M.J., Pignatelli M., and Adams J.C. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am. J. Pathol. 162 (2003) 69-80
17. Puppa G., Maisonneuve P., Sonzogni A., Masullo M., Chiappa A., Valerio M., Zampino M.G., Franceschetti I., Capelli P., Chilosi M., Menestrina F., Viale G., and Pelosi G. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Brit. J. Cancer 96 (2007) 1118-1126
18. Maitra A., Iacobuzio-Donahue C., Rahman A., Sohn T.A., Argani P., Meyer R., Yeo C.J., Cameron J.L., Goggins M., Kern S.E., Ashfaq R., Hruban R.H., and Wilentz R.E. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am. J. Clin. Pathol. 118 (2002) 52-59
19. Yamaguchi H., Inoue T., Eguchi T., Miyasaka Y., Ohuchida K., Mizumoto K., Yamada T., Yamaguchi K., Tanaka M., and Tsuneyoshi M. Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod. Pathol. 20 (2007) 552-561
20. Yoder B.J., Tso E., Skacel M., Pettay J., Tarr S., Budd T., Tubbs R.R., Adams J.C., and Hicks D.G. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin. Cancer Res. 11 (2005) 186-192
21. Rodriguez-Pinilla S.M., Sarrio D., Honrado E., Hardisson D., Calero F., Benitez J., and Palacios J. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin. Cancer Res. 12 (2006) 1533-1539
22. Daponte A., Kostopoulou E., Minas M., Koukoulis G., and Messinis I.E. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer. Anticancer Res. 28 (2008) 1905-1910
23. Wen Y.H., Yee H., Goswami S., and Shukla P.S. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int. J. Gynecol. Pathol. 28 (2009) 187-192
24. Goncharuk V.N., Ross J.S., and Carlson J.A. Actin-binding protein fascin expression in skin neoplasia. J. Cutan. Pathol. 29 (2002) 430-438
25. Sonderbye L., Meehan S., Palsson R., Ahsan N., Ladefoged J., and Langhoff E. Immunohistochemical study of actin binding protein (p55) in the human kidney. Transplantation 65 (1998) 1004-1008
26. Chen G., Zhang F.R., Ren J., Tao L.H., Shen Z.Y., Lv Z., Yu S.J., Dong B.F., Xu L.Y., and Li E.M. Expression of fascin in thyroid neoplasms: a novel diagnostic marker. J. Cancer Res. Clin. Oncol. 134 (2008) 947-951
27. Kabukcuoglu S., Ozalp S.S., Oner U., Acikalin M.F., Yalcin O.T., and Colak E. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur. J. Gynaecol. Oncol. 26 (2005) 636-641
28. Darnel A.D., Behmoaram E., Vollmer R.T., Corcos J., Bijian K., Sircar K., Su J., Jiao J., Aoui-Jamali M.A., and Bismar T.A. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin. Cancer Res. 15 (2009) 1376-1383
29. Gunal A., Onguru O., Safali M., and Beyzadeoglu M. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas. Neuropathology 28 (2008) 382-386
30. Hwang J.H., Smith C.A., Salhia B., and Rutka J.T. The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 10 (2008) 149-159
31. Soukup V., Babjuk M., Duskova J., Pesl M., Szakaczova M., Zamecnik L., and Dvoracek J. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?. Urol. Int. 80 (2008) 413-418
32. Pelosi G., Pastorino U., Pasini F., Maissoneuve P., Fraggetta F., Iannucci A., Sonzogni A., De M.G., Terzi A., Durante E., Bresaola E., Pezzella F., and Viale G. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Brit. J. Cancer 88 (2003) 537-547
33. Pelosi G., Pasini F., Fraggetta F., Pastorino U., Iannucci A., Maisonneuve P., Arrigoni G., De Manzoni G., Bresaola E., and Viale G. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42 (2003) 203-213
34. Choi P.J., Yang D.K., Son C.H., Lee K.E., Lee J.I., and Roh M.S. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Eur. J. Cardio - Thorac. Surg. 30 (2006) 538-542
35. Xie J.J., Xu L.Y., Zhang H.H., Cai W.J., Mai R.Q., Xie Y.M., Yang Z.M., Niu Y.D., Shen Z.Y., and Li E.M. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem. Biophys. Res. Commun. 337 (2005) 355-362
36. Adiseshaiah P., Lindner D.J., Kalvakolanu D.V., and Reddy S.P. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res. 67 (2007) 6204-6211
37. Hashimoto Y., Skacel M., Lavery I.C., Mukherjee A.L., Casey G., and Adams J.C. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6 (2006) 241
38. Kabukcuoglu S., Oner U., Ozalp S.S., Dundar E., Yalcin O.T., and Colak E. Prognostic significance of fascin expression in endometrioid carcinoma. Eur. J. Gynaecol. Oncol. 27 (2006) 481-486
39. Kureishy N., Sapountzi V., Prag S., Anilkumar N., and Adams J.C. Fascins, and their roles in cell structure and function. Bioessays 24 (2002) 350-361
40. Vignjevic D., Kojima S., Aratyn Y., Danciu O., Svitkina T., and Borisy G.G. Role of fascin in filopodial protrusion. J. Cell Biol. 174 (2006) 863-875
41. Aratyn Y.S., Schaus T.E., Taylor E.W., and Borisy G.G. Intrinsic dynamic behavior of fascin in filopodia. Mol. Biol. Cell 18 (2007) 3928-3940
42. Vignjevic D., Schoumacher M., Gavert N., Janssen K.P., Jih G., Lae M., Louvard D., Ben-Ze'ev A., and Robine S. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67 (2007) 6844-6853
43. Grothey A., Hashizume R., Ji H., Tubb B.E., Patrick Jr. C.W., Yu D., Mooney E.E., and McCrea P.D. C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19 (2000) 4864-4875
44. Guvakova M.A., Boettiger D., and Adams J.C. Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor. Int. J. Biochem. Cell Biol. 34 (2002) 685-698
45. Shonukan O., Bagayogo I., McCrea P., Chao M., and Hempstead B. Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene 22 (2003) 3616-3623
46. Ramires M., David L., Leitao D., Seixas M., Sansonetty F., and Sobrinho-Simoes M. Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J. Pathol. 182 (1997) 62-67
47. Jung A., Schrauder M., Oswald U., Knoll C., Sellberg P., Palmqvist R., Niedobitek G., Brabletz T., and Kirchner T. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am. J. Pathol. 159 (2001) 1613-1617
48. Hou Y., Yang L., Mou M., Hou Y., Zhang A., Pan N., Qiang R., Wei L., and Zhang N. Annexin A2 regulates the levels of plasmin, S100A10 and fascin in L5178Y cells. Cancer Invest. 26 (2008) 809-815
49. Wong V., Ching D., McCrea P.D., and Firestone G.L. Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J. Biol. Chem. 274 (1999) 5443-5453
50. Guan Y., Woo P.L., Rubenstein N.M., and Firestone G.L. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. Exp. Cell Res. 273 (2002) 1-11
51. Zhang S., Lin Q.D., and DI W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int. J. Gynecol. Cancer 16 (2006) 522-531
52. Hashimoto Y., Loftis D.W., and Adams J.C. Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells. PLoS ONE 4 (2009) e5130
53. Anilkumar N., Parsons M., Monk R., Ng T., and Adams J.C. Interaction of fascin and protein kinase C alpha: a novel intersection in cell adhesion and motility. EMBO J. 22 (2003) 5390-5402
54. Ono S., Yamakita Y., Yamashiro S., Matsudaira P.T., Gnarra J.R., Obinata T., and Matsumura F. Identification of an actin binding region and a protein kinase C phosphorylation site on human fascin. J. Biol. Chem. 272 (1997) 2527-2533
55. Hashimoto Y., Parsons M., and Adams J.C. Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol. Biol. Cell 18 (2007) 4591-4602
56. Adams J.C., and Schwartz M.A. Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42. J. Cell Biol. 150 (2000) 807-822
57. Parsons M., and Adams J.C. Rac regulates the interaction of fascin with protein kinase C in cell migration. J. Cell Sci. 121 (2008) 2805-2813
58. Adams J.C., Clelland J.D., Collett G.D., Matsumura F., Yamashiro S., and Zhang L. Cell-matrix adhesions differentially regulate fascin phosphorylation. Mol. Biol. Cell 10 (1999) 4177-4190
59. Ishikawa R., Yamashiro S., Kohama K., and Matsumura F. Regulation of actin binding and actin bundling activities of fascin by caldesmon coupled with tropomyosin. J. Biol. Chem. 273 (1998) 26991-26997